The AstraZeneca PLC ADR
inched 0.59% increased to $52.55 Thursday, on what proved to be an all-around blended buying and selling session for the stock market, with the NASDAQ Composite Index
rising 0.55% to 13,530.91 and the Dow Jones Industrial Common
falling 0.04% to 31,176.01. AstraZeneca PLC ADR closed $12.39 under its 52-week excessive ($64.94), which the corporate achieved on July 20th.
The ADR outperformed a few of its rivals Thursday, as AbbVie Inc.
fell 1.21% to $111.26, Amgen Inc.
fell 0.13% to $252.03, and Gilead Sciences Inc.
fell 1.49% to $66.98. Buying and selling quantity (16.Zero M) eclipsed its 50-day common quantity of 11.2 M.